Patrick Frost, PhD

Patrick Frost, PhD

Jan 13, 2016

Group 6 Copy 45
-1
    Please wait...

    About This Project

    BBRI and Los Angeles VA Medical Center

    Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody-producing white blood cells). Low oxygen levels (called hypoxia) in the bone marrow increases gene expression in MM tumor cells as part of an adaptive survival response. We are targeting this hypoxic response with an experimental drug that blocks expression of these genes to ask if this molecule kills MM in the bone marrow. This is a novel approach to treat MM, an incurable disease.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Lost in the mountains: Describing new species in the High Atlas Mountains of Morocco

    Biodiversity is not evenly distributed on the planet, but is concentrated in hotspots, with high conservation...

    How do gorillas see the world?

    An animals' "umwelt" is the way in which they perceive the world. With the use of eye-tracking technology...

    The first look at pumas and reintroduced endangered wolves of northern México

    Puma (Puma concolor) ecology in northern Mexico is essentially unknown and thus far, has relied on camera...

    Backer Badge Funded